Cargando…

Assessment of Interleukin 16 Serum Levels and Skin Expression in Psoriasis Patients in Correlation with Clinical Severity of the Disease

Interleukin 16 (IL-16) has been described as a significant cytokine involved in the recruitment of CD4+ cells during inflammation; however, its potential role in psoriasis has not been defined. Our aim was to investigate the IL-16 serum levels and IL-16 mRNA skin expression in psoriasis patients in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Purzycka-Bohdan, Dorota, Szczerkowska-Dobosz, Aneta, Zablotna, Monika, Wierzbicka, Justyna, Piotrowska, Anna, Zmijewski, Michal A., Nedoszytko, Boguslaw, Nowicki, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082815/ https://www.ncbi.nlm.nih.gov/pubmed/27788245 http://dx.doi.org/10.1371/journal.pone.0165577

Ejemplares similares

The significance of Toll-like receptor (TLR) 2 and 9 gene polymorphisms in psoriasis
por: Zabłotna, Monika, et al.
Publicado: (2017)

The Effects of Vitamin D on the Expression of IL-33 and Its Receptor ST2 in Skin Cells; Potential Implication for Psoriasis
por: Wierzbicka, Justyna M., et al.
Publicado: (2021)

Chemokine Profile in Psoriasis Patients in Correlation with Disease Severity and Pruritus
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2022)

Assessment of the Potential Role of Selected Single Nucleotide Polymorphisms (SNPs) of Genes Related to the Functioning of Regulatory T Cells in the Pathogenesis of Psoriasis
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2023)

Significance of interleukin-31 (IL-31) gene polymorphisms and IL-31 serum level in psoriasis in correlation with pruritus
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2021)

Considerations of the Genetic Background of Obesity among Patients with Psoriasis
por: Czarnecka, Anna, et al.
Publicado: (2023)

An Observational Study of 147 Psoriasis Patients: Overweightness and Obesity as a Significant Clinical Factors Correlated with Psoriasis
por: Czarnecka, Anna, et al.
Publicado: (2023)

Analysis of the Potential Genetic Links between Psoriasis and Cardiovascular Risk Factors
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2021)

Genetic background of skin barrier dysfunction in the pathogenesis of psoriasis vulgaris
por: Stawczyk-Macieja, Marta, et al.
Publicado: (2015)

Comment on the article “Buschke-Löwenstein tumour associated with low-risk human papillomavirus genotypes successfully treated surgically”
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2022)

New Insights into Psoriasis
por: Nedoszytko, Boguslaw, et al.
Publicado: (2022)

Hyperhidrosis: disease aetiology, classification and management in the light of modern treatment modalities
por: Kisielnicka, Anna, et al.
Publicado: (2022)

Acquired facial lipoatrophy: pathogenesis and therapeutic options
por: Szczerkowska-Dobosz, Aneta, et al.
Publicado: (2015)

Juvenile xanthogranuloma: a rare benign histiocytic disorder
por: Szczerkowska-Dobosz, Aneta, et al.
Publicado: (2014)

The Analysis of a Genome-Wide Association Study (GWAS) of Overweight and Obesity in Psoriasis
por: Kisielnicka, Anna, et al.
Publicado: (2022)

Modulation of dermal equivalent of hypothalamus-pituitary-adrenal axis in mastocytosis
por: Antoniewicz, Jakub, et al.
Publicado: (2021)

Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2022)

Pathogenesis of psoriasis in the “omic” era. Part II. Genetic, genomic and epigenetic changes in psoriasis
por: Nedoszytko, Bogusław, et al.
Publicado: (2020)

Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Buschke-Löwenstein tumour associated with low-risk human papillomavirus genotypes successfully treated surgically
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2019)

Lysosome Alterations in the Human Epithelial Cell Line HaCaT and Skin Specimens: Relevance to Psoriasis
por: Bocheńska, Katarzyna, et al.
Publicado: (2019)

–2518 A/G MCP-1 but not –403 G/A RANTES gene polymorphism is associated with enhanced risk of basal cell carcinoma
por: Sobjanek, Michał, et al.
Publicado: (2016)

The influence of body weight of patients with chronic plaque psoriasis on biological treatment response
por: Kisielnicka, Anna, et al.
Publicado: (2020)

The −1154 G/A VEGF gene polymorphism is associated with the incidence of basal cell carcinoma in patients from northern Poland
por: Sobjanek, Michał, et al.
Publicado: (2014)

Pathogenesis of psoriasis in the “omic” era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances
por: Samotij, Dominik, et al.
Publicado: (2020)

Correction: Bocheńska, K. et al. Lysosome Alterations in the Human Epithelial Cell Line HaCaT and Skin Specimens: Relevance to Psoriasis. Int. J. Mol. Sci. 2019, 20, 2255
por: Bocheńska, Katarzyna, et al.
Publicado: (2020)

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis
por: Nedoszytko, Bogusław, et al.
Publicado: (2017)

Pathogenesis of psoriasis in the “omic” era. Part IV. Epidemiology, genetics, immunopathogenesis, clinical manifestation and treatment of psoriatic arthritis
por: Szczerkowska-Dobosz, Aneta, et al.
Publicado: (2020)

–308 G/A TNF-α gene polymorphism influences the course of basal cell carcinoma in a Polish population
por: Sobjanek, Michał, et al.
Publicado: (2015)

Tattooing in Psoriasis: A Questionnaire-Based Analysis of 150 Patients
por: Rogowska, Patrycja, et al.
Publicado: (2022)

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part I: Treg properties and functions
por: Nedoszytko, Bogusław, et al.
Publicado: (2017)

The role of polymorphism of interleukin-2, -10, -13 and TNF-α genes in cutaneous T-cell lymphoma pathogenesis
por: Nedoszytko, Boguslaw, et al.
Publicado: (2016)

Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis
por: Nedoszytko, Bogusław, et al.
Publicado: (2014)

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs’ activation and function
por: Nedoszytko, Bogusław, et al.
Publicado: (2017)

The Brain–Skin Axis in Psoriasis—Psychological, Psychiatric, Hormonal, and Dermatological Aspects
por: Marek-Jozefowicz, Luiza, et al.
Publicado: (2022)

-2518A/G polymorphism of monocyte chemotactic protein 1 (MCP-1/CCL2) is associated with cutaneous mastocytosis
por: Ługowska-Umer, Hanna, et al.
Publicado: (2022)

Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy
por: Brożyna, Anna A., et al.
Publicado: (2022)

Molecular action of isoflavone genistein in the human epithelial cell line HaCaT
por: Smolińska, Elwira, et al.
Publicado: (2018)

Clinical internship at the Department of Dermatology, Venereology and Allergology, Medical University of Gdansk
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2017)

ERAP1 and HLA-C*06 are strongly associated with the risk of psoriasis in the population of northern Poland
por: Stawczyk-Macieja, Marta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_560saqh6ki0ocr1eksboc8nknr